Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: Identification of an H2-Kd-restricted CTL epitope

Gene Therapy

Volumn 7, Issue 23, 2000, Pages 2036-2040

  Gambotto, A ^a   Dworacki, G ^a   Cicinnati, V ^a   Kenniston, T ^a   Steitz, J ^b   Tuting T ^b   Robbins, P D ^a   DeLeo, A B ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

BALB c; EGFP; Epitope; H2 Kd

Indexed keywords

BETA GALACTOSIDASE; BINDING PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; CHROMIUM 51; COMPLEMENTARY DNA; EPITOPE; GAMMA INTERFERON; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; PEPTIDE DERIVATIVE; RECOMBINANT INTERLEUKIN 2; RECOMBINANT PROTEIN; TUMOR ANTIGEN; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN; VIRUS HEMAGGLUTININ; VIRUS VACCINE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; IMAGING SYSTEM; IMMUNOGENICITY; MARKER GENE; METHODOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; SARCOMA CELL; SPLEEN CELL; VIRUS RECOMBINANT;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; GREEN FLUORESCENT PROTEINS; H-2 ANTIGENS; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0034502576     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301335     Document Type: Article

References (24)

1. DNA vaccines
2. DNA immunization targeting the skin: Molecular control of adaptive immunity
3. The new vaccines: Building viruses that elicit anti-tumor immunity
4. Active immunotherapy of cancer with a nonreplicating recombinant fowlpoxvirus encoding a model tumor-associated antigen
5. Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen
6. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines
7. DNA-based immunization by in vivo transfection of dendritic cells
8. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: Studies with the model tumor antigen β-galactosidase and the BALB/c Meth A p53 tumor-specific antigen
9. Induction of tumor antigen-specific immunity using DNA immunization in mice
10. Green fluorescent protein as a marker for gene expression
11. A 'humanized' green fluorescent protein cDNA adapted for high-level expression in mammalian cells
12. Improved green fluorescence
13. Green fluorescent protein. The green revolution
14. Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells
15. FACS-optimized mutants of the green fluorescent protein (GFP)
16. Immune response to green fluorescent protein: Implications for gene therapy
17. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains
18. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids
19. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes
20. Dendritic cells as initiatiors of tumor immune responses: A possible strategy for tumor immunotherapy?
21. Dendritic cells as adjuvants for immune-mediated resistance to tumors
22. Bone marrow-derived dendritic cells genetically modified to express tumor-associated antigens induce antitumor immunity in vivo
23. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity
24. Construction of adenovirus vectors through Crelox recombination